Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$118,668,256
-$14,033,725 QoQ
Shares Held
939,277
-1.4% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#130
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STOREBRAND ASSET MANAGEMENT AS holds $1,607,022,504 across 10 Drug Manufacturers - General names. GILD ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
471,742 | $565,821,554 | |
| 2 | ABBV |
AbbVie Inc.
|
1,078,470 | $271,386,190 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,685,911 | $216,639,563 | |
| 4 | PFE |
Pfizer Inc
|
5,190,196 | $124,979,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
939,277 | $118,668,256 | |
| 6 | AMGN |
Amgen Inc
|
325,992 | $118,048,223 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,753,508 | $101,037,130 | |
| 8 | JNJ |
Johnson & Johnson
|
342,270 | $86,926,311 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,668,256 | 939,277 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $132,701,981 | 952,156 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $115,467,164 | 940,746 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $106,058,946 | 955,486 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $106,933,117 | 964,491 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $103,090,930 | 920,044 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $73,440,154 | 795,065 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $52,232,655 | 623,004 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $55,490,395 | 808,780 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $61,439,902 | 838,770 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $78,188,583 | 965,172 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $74,490,210 | 993,998 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $78,071,910 | 1,013,000 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $83,501,339 | 1,006,404 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $82,515,156 | 961,155 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $60,239,729 | 976,491 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $63,001,449 | 1,019,276 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $60,265,000 | 1,013,709 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $60,069,744 | 827,293 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $49,941,283 | 714,979 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $49,773,867 | 722,827 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $47,623,391 | 736,862 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $42,304,741 | 726,137 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $42,465,133 | 672,023 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $44,752,074 | 581,649 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $45,208,792 | 604,719 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||